Pulmicort and Nasal disorder - a phase IV clinical study of FDA data

Summary:

Nasal disorder is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are male, 40-49 old, also take Spiriva, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Nasal disorder when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Nasal disorder?

Nasal disorder (diseases of nose) is found to be associated with 369 drugs and 449 conditions by eHealthMe. Check the latest studies of Nasal disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 73 people (0.21%) have Nasal disorder.

Among these 73 people:

What is the gender of people who have Nasal disorder when taking Pulmicort? *

female: 38.03 %
male: 61.97 %

What is the age of people who have Nasal disorder when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Nasal disorder? *

Wheezing (a high-pitched whistling sound made while you breath): 57 people, 78.08%
Dyspnea (difficult or laboured breathing): 57 people, 78.08%
Productive Cough: 50 people, 68.49%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 44 people, 60.27%
Dyspnea Exertional: 43 people, 58.90%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 40 people, 54.79%
Nasopharyngitis (inflammation of the nasopharynx): 39 people, 53.42%
Cough: 35 people, 47.95%
Chest Pain: 34 people, 46.58%
Eosinophil Count Increased: 33 people, 45.21%

What are the existing conditions these people have? *

Hypersensitivity: 5 people, 6.85%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 6.85%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 2.74%
Allergic Rhinitis: 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Nasal disorder?

- Check whether Nasal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Nasal disorder treatments and more:

Nasal disorder (3,871 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasal disorder:

Nasal disorder (369 drugs)

Browse all the conditions that are associated with Nasal disorder:

Nasal disorder (449 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.